Wernicke-Korsakoff syndrome: Difference between revisions
3amrbadawy (talk | contribs) No edit summary |
(Strip excess bold) |
||
| (41 intermediate revisions by 10 users not shown) | |||
| Line 1: | Line 1: | ||
==Background== | ==Background== | ||
* | *Wernicke's Encephalopathy (WE): acute neurologic syndrome caused by [[thiamine deficiency]] | ||
* | *Korsakoff's Psychosis (KS): chronic neuropsychiatric syndrome caused by thiamine deficiency | ||
*Wernicke-Korsakoff Syndrome (WKS): presence of | *Wernicke-Korsakoff Syndrome (WKS): presence of Wernicke's Encephalopathy + Korsakoff's Psychosis simultaneously | ||
*First described by Carl Wernicke in 1881; remains one of the most underdiagnosed and undertreated neurologic emergencies | |||
===Epidemiology=== | ===Epidemiology=== | ||
*Only 20% identified before death | *Autopsy prevalence ~2% in the general population; up to 12.5% in patients with alcohol use disorder<ref>Donnino MW, Vega J, Miller J, Walsh M. Myths and misconceptions of Wernicke's encephalopathy: what every emergency physician should know. Ann Emerg Med. 2007;50(6):715-21.</ref> | ||
*Only ~20% of cases are identified before death; failure of diagnosis leads to ~20% mortality and ~75% permanent neurologic damage | |||
*Classic triad (encephalopathy, oculomotor dysfunction, ataxia) is present in only ~10% of patients<ref>Sinha S, Kataria A, Kolla BP, et al. Wernicke Encephalopathy-Clinical Pearls. Mayo Clin Proc. 2019;94(6):1065-1072.</ref> | |||
*~80% of patients with untreated WE progress to Korsakoff syndrome | |||
*Not limited to alcoholics — increasingly recognized post-bariatric surgery (~10% prevalence), in hyperemesis gravidarum, cancer, and critically ill patients | |||
===Pathophysiology=== | ===Pathophysiology=== | ||
* | *Thiamine (vitamin B1) is a cofactor for enzymes critical to cerebral energy metabolism: | ||
**Energy production pathways: pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, transketolase (Krebs cycle, pentose phosphate pathway) | |||
** | ***Deficiency leads to impaired ATP production → [[lactic acidosis]], neuronal/astrocytic injury, and altered brain metabolism | ||
***Brain regions with high metabolic demand are most vulnerable | |||
** | **Lipid metabolism (including myelin sheath formation) | ||
* | ***Alterations in myelination leads to peripheral neuropathy | ||
* | *Thiamine half-life is only ~96 minutes; body stores are depleted within 2-3 weeks without intake | ||
*Brain lesions/atrophy usually occur in (bilateral, symmetric): | |||
**Mammillary bodies (nearly all cases — involvement is pathognomonic) | |||
**Medial thalamus | |||
**Periaqueductal gray matter | |||
**3rd/4th ventricle walls | |||
**Tectal plate | |||
**Cerebellum (especially vermis) | |||
**Frontal lobe (atypical) | |||
===Causes=== | ===Causes=== | ||
* | *Thiamine (vitamin B1) deficiency caused by: | ||
**Chronic alcoholism | **Insufficient intake | ||
***Chronic [[alcoholism]] (most common cause in Western countries) | |||
***Starvation/[[anorexia]]/eating disorders | |||
***Severe [[vomiting]]/[[diarrhea]]/[[hyperemesis gravidarum]] | |||
***Unbalanced or thiamine-deficient TPN | |||
***Self-imposed dietary restriction | |||
**Malabsorption | |||
***Post-bariatric surgery (especially Roux-en-Y gastric bypass) | |||
***Post-gastrectomy | |||
***[[IBD]], [[celiac disease]] | |||
***[[Pancreatitis]] | |||
***Intestinal obstruction | |||
**Increased metabolic requirements | |||
***Malignancy/cancer chemotherapy | |||
***[[Thyrotoxicosis]] | |||
***[[Sepsis]], critical illness | |||
***Refeeding syndrome | |||
***Carbohydrate loading (iatrogenic — can unmask subclinical deficiency) | |||
**Thiamine losses | |||
***[[Hemodialysis]]/peritoneal dialysis | |||
**Miscellaneous: [[AIDS]], chronic liver disease, prolonged ICU admission, magnesium depletion (magnesium is a cofactor for thiamine-dependent enzymes) | |||
{{Thiamine deficiency types}} | |||
==Clinical Features== | ==Clinical Features== | ||
=== | ===Wernicke's Encephalopathy=== | ||
*Classic triad: encephalopathy, oculomotor dysfunction, gait ataxia | *Classic triad: [[encephalopathy]], oculomotor dysfunction, gait [[ataxia]] | ||
*werNICke mnemonic: | **Classic triad present in only ~10% of cases — do NOT rely on complete triad to make diagnosis | ||
** | *werNICke mnemonic: | ||
** | **[[nystagmus|Nystagmus]]/ophthalmoplegia | ||
** | ***Horizontal nystagmus is the most common ocular finding (not complete ophthalmoplegia) | ||
*Other | ***Other ocular findings: bilateral 6th nerve palsy, conjugate gaze palsy, pupillary abnormality, retinal hemorrhage, ptosis | ||
***May progress to complete ophthalmoplegia | |||
**Incoordination/[[ataxia]] | |||
***Legs affected more than arms (vestibular + cerebellar dysfunction) | |||
***Primarily affects gait; arms and speech usually spared | |||
**[[confusion|Confusion]]/memory impairment | |||
***Delirium/encephalopathy is the most consistent clinical feature | |||
***May present as apathy, inattention, disorientation, or progress to coma | |||
*Other symptoms: | |||
**[[Hypotension]], [[tachycardia]], ECG abnormalities | |||
**[[Dyspnea]] on exertion, [[CHF]] symptoms (cardiac beriberi) | |||
**[[Hypothermia]] | |||
**Peripheral neuropathy (paresthesias, especially distal lower extremities — dry [[beriberi]]) | |||
**Vestibular dysfunction (without hearing loss) | |||
**[[Coma]] | |||
===Korsakoff's Psychosis=== | |||
*Usually develops as a consequence of untreated or inadequately treated WE | |||
*Anterograde > retrograde amnesia (disproportionate to other cognitive functions) | |||
*Confabulation (often spontaneous) | |||
*Confusion, disorientation, apathy | |||
*Lack of insight into deficits | |||
*Largely irreversible | |||
==Differential Diagnosis== | |||
{{Ethanol DDX}} | |||
{{Vitamin deficiencies DDX}} | |||
*Other diagnoses to consider: | |||
**[[Stroke]]/cerebellar infarction (can mimic entire triad — ophthalmoplegia, ataxia, AMS) | |||
**[[Hepatic encephalopathy]] | |||
**[[Hypoglycemia]] | |||
**Sepsis-associated encephalopathy | |||
**[[Meningitis]]/[[encephalitis]] | |||
**Metronidazole-induced encephalopathy (similar MRI findings; can coexist in malnourished patients on metronidazole) | |||
**Creutzfeldt-Jakob disease (CJD — may have similar thalamic/basal ganglia signal changes on MRI, but spares mammillary bodies) | |||
**[[Carbon monoxide poisoning]] | |||
**Central pontine myelinolysis | |||
**[[Delirium tremens]] | |||
==Evaluation== | |||
[[File:MRI FLAIR sequence Wernicke Encephalopathy.jpg|thumb|Axial MRI FLAIR image showing hyperintense signal in the mesial dorsal thalami, a common finding in Wernicke encephalopathy]] | |||
===Workup=== | |||
*WE is a '''clinical diagnosis''' — do NOT delay treatment for workup | |||
*Labs (to exclude alternative diagnoses and identify co-morbid conditions): | |||
**[[BMP]]— electrolytes, glucose, renal function, hepatic function | |||
**[[CBC]] | |||
**[[Magnesium]] level — critical; hypomagnesemia causes resistance to thiamine therapy | |||
**[[Lactate]] — may be elevated (thiamine is a cofactor for pyruvate dehydrogenase) | |||
**Blood alcohol level | |||
**Serum thiamine level (whole blood thiamine preferred over serum/plasma): | |||
***Draw '''before''' administering thiamine if possible, but '''never delay treatment''' to obtain | |||
***Normal range generally 70-180 nmol/L, but sensitivity and specificity are poorly defined | |||
***A normal thiamine level does NOT exclude WE<ref>Ono K, Hayano S, Kashima M. Wernicke encephalopathy: limitations in a laboratory and radiological diagnosis. BMJ Case Rep. 2023;16(12):e254786.</ref> | |||
**Other labs as clinically indicated: [[TSH]], [[ammonia]], [[lipase]], toxicology screen, blood cultures | |||
*Consider [[lumbar puncture]] if [[meningitis]]/[[encephalitis]] suspected — CSF in WKS typically shows normal or mildly elevated protein without pleocytosis | |||
===Imaging=== | |||
*CT head: sensitivity only ~13% for WE; primary role is to exclude other pathology (hemorrhage, mass, infarct)<ref>Medscape. Wernicke Encephalopathy Workup. Available at: https://emedicine.medscape.com/article/794583-workup</ref> | |||
*MRI brain (best imaging modality if obtained): | |||
**Sensitivity ~53%, specificity ~93%, positive predictive value ~89% | |||
***MRI is better at confirming the diagnosis than ruling it out | |||
***A '''normal MRI does NOT exclude WE''' — do not withhold treatment based on normal imaging | |||
**Classic findings: bilateral, symmetric T2/FLAIR hyperintensities in: | |||
***Mammillary bodies (most distinctive finding; contrast enhancement may be pathognomonic) | |||
***Periventricular/medial thalamus | |||
***Periaqueductal gray matter | |||
***Tectal plate | |||
***Cerebellar vermis (atypical but recognized) | |||
**DWI may show restricted diffusion (helps differentiate vasogenic vs cytotoxic edema) | |||
**Findings may normalize within days of starting thiamine therapy | |||
*Communicate suspected diagnosis to radiologists so protocols optimized for mammillary bodies, thalami, and periaqueductal region are used | |||
===Diagnosis=== | |||
*Clinical diagnosis — maintain high index of suspicion | |||
*Caine criteria (operational diagnostic criteria; ~85% sensitive when ≥2 present)<ref>Caine D, Halliday GM, Kril JJ, Harper CG. Operational criteria for the classification of chronic alcoholics: identification of Wernicke's encephalopathy. J Neurol Neurosurg Psychiatry. 1997;62(1):51-60.</ref>: | |||
**Nutritional deficiency (any state, not just alcoholism) | |||
**Ocular findings (ophthalmoplegia, nystagmus) | |||
**Cerebellar dysfunction (ataxia) | |||
**Altered mental status or mild memory impairment | |||
*Per EFNS guidelines, clinical diagnosis of WE in alcoholics requires at least 2 of the following<ref>Galvin R, Bråthen G, Ivashynka A, et al. EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy. Eur J Neurol. 2010;17(12):1408-18.</ref>: | |||
**Dietary deficiencies | |||
**Ocular findings (ophthalmoplegia, nystagmus) | |||
**Cerebellar dysfunction (ataxia) | |||
**Mental status change or mild memory impairment | |||
==Management== | |||
''If you suspect, then treat! Confirming diagnosis is difficult, treatment is low risk and effective, and morbidity/mortality is high if untreated'' | |||
=== | ===Acute Treatment=== | ||
* | *[[Thiamine]] — IV administration is critical; oral absorption is unreliable in at-risk patients | ||
**Royal College of Physicians / UK guideline (widely adopted): | |||
***500 mg IV over 30 min TID x 2-3 days → then 250 mg IV/IM once daily x 3-5 days → then 100 mg PO daily until patient no longer at risk | |||
**EFNS guideline: | |||
***200 mg IV TID (diluted in 100 mL NS or D5W, infused over 30 min) | |||
**100 mg/day (e.g., banana bag dose) is likely insufficient — especially in patients with alcohol use disorder | |||
**Thiamine has a short half-life (~96 min); multiple daily doses are more effective than once-daily dosing | |||
**Overall safety of thiamine is very good; anaphylaxis risk with IV thiamine is rare | |||
=== | ===Key Principles=== | ||
* | *Give thiamine BEFORE glucose in any at-risk patient requiring dextrose | ||
**Glucose without thiamine can precipitate or worsen WE by driving remaining thiamine intracellularly | |||
**If both are urgently needed (e.g., symptomatic hypoglycemia), give them simultaneously — do not withhold glucose to wait for thiamine | |||
*Give [[magnesium]] | |||
**Magnesium is a cofactor for thiamine-dependent enzymes | |||
**Hypomagnesemia may cause resistance to thiamine therapy | |||
**Replete magnesium early and aggressively | |||
*Replete other vitamins/electrolytes as indicated ([[folate]], multivitamin, [[pyridoxine]]) | |||
*Monitor for [[refeeding syndrome]] in severely malnourished patients | |||
*Treatment response can take days to weeks; lack of immediate improvement does not exclude WE | |||
== | ===Treatment Response (Expected Timeline)=== | ||
*Oculomotor dysfunction: often begins improving within hours to days | |||
*Confusion/encephalopathy: may take days to weeks | |||
*Ataxia: slowest to improve; may be permanent | |||
*Korsakoff psychosis: largely irreversible once established | |||
== | ===Common Pitfalls=== | ||
WE/ | {| class="wikitable" | ||
|- | |||
! Pitfall !! Correct Approach | |||
|- | |||
| Believing WE only affects alcoholics || Any nutritionally deficient state can cause WE — consider post-bariatric surgery, cancer, hyperemesis, critical illness | |||
|- | |||
| Waiting for the complete classic triad || Triad present in only ~10%; any component + risk factor should prompt treatment | |||
|- | |||
| Using 100 mg IV thiamine (banana bag) as treatment dose || 100 mg is prophylactic, not therapeutic; treatment requires 200-500 mg IV TID | |||
|- | |||
| Relying on labs/imaging to confirm before treating || Clinical diagnosis; normal thiamine levels and normal MRI do NOT exclude WE | |||
|- | |||
| Withholding glucose to wait for thiamine || If hypoglycemia is symptomatic, give both simultaneously; do not delay glucose | |||
|- | |||
| Forgetting to check/replete magnesium || Hypomagnesemia impairs thiamine utilization; always co-replete | |||
|- | |||
| Confusing WE with cerebellar stroke || Both present with ophthalmoplegia, ataxia, AMS — always consider WE in differential | |||
|} | |||
== | ==Medication Dosing== | ||
{{MedicationDose | |||
| drug = Thiamine | |||
| dose = 500mg IV over 30min TID x 2-3 days, then 250mg IV/IM daily x 3-5 days, then 100mg PO daily | |||
| route = IV | |||
| context = Treatment dose for confirmed/suspected Wernicke encephalopathy | |||
| indication = Wernicke-Korsakoff syndrome | |||
| population = Adult | |||
| notes = 100mg (banana bag dose) is prophylactic only, NOT therapeutic; treatment requires 200-500mg IV TID | |||
}} | |||
* | ==Disposition== | ||
** | *Admit (inpatient medicine or neurology service) | ||
** | **Ensures continued IV thiamine and magnesium administration | ||
** | **Observation for development of Korsakoff syndrome | ||
**Evaluation for cardiovascular beriberi | |||
**Address underlying cause of thiamine deficiency | |||
*<25% of patients show full recovery, ~50% show partial recovery, the remainder show no response despite treatment<ref>https://www.alz.org/alzheimers-dementia/what-is-dementia/types-of-dementia/korsakoff-syndrome</ref> | |||
*~80% of patients with untreated WE develop Korsakoff syndrome | |||
*Refer patients with alcohol use disorder to cessation programs; monitor for [[alcohol withdrawal]] | |||
== | ==Prevention== | ||
* | *Give parenteral thiamine to '''all at-risk patients''' presenting to the ED — do not wait for symptoms | ||
* | *After bariatric surgery: follow thiamine status for at least 6 months; supplement parenterally as needed | ||
{{Vitamin prophylaxis for ETOH}} | |||
==See Also== | ==See Also== | ||
*[[Alcohol | *[[Thiamine deficiency]] | ||
*[[Beriberi]] | |||
*[[Alcohol withdrawal]] | |||
*[[Alcoholic ketoacidosis]] | *[[Alcoholic ketoacidosis]] | ||
*[[ | *[[Refeeding syndrome]] | ||
{{Ethanol DDX}} | |||
==External Links== | |||
*[ | *[https://emergencycarebc.ca/clinical_resource/clinical-summary/wernickes-encephalopathy-diagnosis-and-treatment/ Emergency Care BC: Wernicke's Encephalopathy Diagnosis and Treatment] | ||
*[ | *[https://emcrit.org/ibcc/wernicke/ EMCrit IBCC: Thiamine Deficiency and Wernicke Encephalopathy] | ||
*[ | *[https://www.ncbi.nlm.nih.gov/books/NBK470344/ StatPearls: Wernicke Encephalopathy] | ||
==References== | ==References== | ||
<references/> | <references/> | ||
[[Category:Neurology]] | |||
[[Category:Toxicology]] | |||
[[Category: | [[Category:FEN]] | ||
Latest revision as of 09:27, 22 March 2026
Background
- Wernicke's Encephalopathy (WE): acute neurologic syndrome caused by thiamine deficiency
- Korsakoff's Psychosis (KS): chronic neuropsychiatric syndrome caused by thiamine deficiency
- Wernicke-Korsakoff Syndrome (WKS): presence of Wernicke's Encephalopathy + Korsakoff's Psychosis simultaneously
- First described by Carl Wernicke in 1881; remains one of the most underdiagnosed and undertreated neurologic emergencies
Epidemiology
- Autopsy prevalence ~2% in the general population; up to 12.5% in patients with alcohol use disorder[1]
- Only ~20% of cases are identified before death; failure of diagnosis leads to ~20% mortality and ~75% permanent neurologic damage
- Classic triad (encephalopathy, oculomotor dysfunction, ataxia) is present in only ~10% of patients[2]
- ~80% of patients with untreated WE progress to Korsakoff syndrome
- Not limited to alcoholics — increasingly recognized post-bariatric surgery (~10% prevalence), in hyperemesis gravidarum, cancer, and critically ill patients
Pathophysiology
- Thiamine (vitamin B1) is a cofactor for enzymes critical to cerebral energy metabolism:
- Energy production pathways: pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, transketolase (Krebs cycle, pentose phosphate pathway)
- Deficiency leads to impaired ATP production → lactic acidosis, neuronal/astrocytic injury, and altered brain metabolism
- Brain regions with high metabolic demand are most vulnerable
- Lipid metabolism (including myelin sheath formation)
- Alterations in myelination leads to peripheral neuropathy
- Energy production pathways: pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, transketolase (Krebs cycle, pentose phosphate pathway)
- Thiamine half-life is only ~96 minutes; body stores are depleted within 2-3 weeks without intake
- Brain lesions/atrophy usually occur in (bilateral, symmetric):
- Mammillary bodies (nearly all cases — involvement is pathognomonic)
- Medial thalamus
- Periaqueductal gray matter
- 3rd/4th ventricle walls
- Tectal plate
- Cerebellum (especially vermis)
- Frontal lobe (atypical)
Causes
- Thiamine (vitamin B1) deficiency caused by:
- Insufficient intake
- Chronic alcoholism (most common cause in Western countries)
- Starvation/anorexia/eating disorders
- Severe vomiting/diarrhea/hyperemesis gravidarum
- Unbalanced or thiamine-deficient TPN
- Self-imposed dietary restriction
- Malabsorption
- Post-bariatric surgery (especially Roux-en-Y gastric bypass)
- Post-gastrectomy
- IBD, celiac disease
- Pancreatitis
- Intestinal obstruction
- Increased metabolic requirements
- Malignancy/cancer chemotherapy
- Thyrotoxicosis
- Sepsis, critical illness
- Refeeding syndrome
- Carbohydrate loading (iatrogenic — can unmask subclinical deficiency)
- Thiamine losses
- Hemodialysis/peritoneal dialysis
- Miscellaneous: AIDS, chronic liver disease, prolonged ICU admission, magnesium depletion (magnesium is a cofactor for thiamine-dependent enzymes)
- Insufficient intake
Thiamine deficiency types
Clinical Features
Wernicke's Encephalopathy
- Classic triad: encephalopathy, oculomotor dysfunction, gait ataxia
- Classic triad present in only ~10% of cases — do NOT rely on complete triad to make diagnosis
- werNICke mnemonic:
- Nystagmus/ophthalmoplegia
- Horizontal nystagmus is the most common ocular finding (not complete ophthalmoplegia)
- Other ocular findings: bilateral 6th nerve palsy, conjugate gaze palsy, pupillary abnormality, retinal hemorrhage, ptosis
- May progress to complete ophthalmoplegia
- Incoordination/ataxia
- Legs affected more than arms (vestibular + cerebellar dysfunction)
- Primarily affects gait; arms and speech usually spared
- Confusion/memory impairment
- Delirium/encephalopathy is the most consistent clinical feature
- May present as apathy, inattention, disorientation, or progress to coma
- Nystagmus/ophthalmoplegia
- Other symptoms:
- Hypotension, tachycardia, ECG abnormalities
- Dyspnea on exertion, CHF symptoms (cardiac beriberi)
- Hypothermia
- Peripheral neuropathy (paresthesias, especially distal lower extremities — dry beriberi)
- Vestibular dysfunction (without hearing loss)
- Coma
Korsakoff's Psychosis
- Usually develops as a consequence of untreated or inadequately treated WE
- Anterograde > retrograde amnesia (disproportionate to other cognitive functions)
- Confabulation (often spontaneous)
- Confusion, disorientation, apathy
- Lack of insight into deficits
- Largely irreversible
Differential Diagnosis
- Ethanol toxicity
- Alcohol use disorder
- Alcohol withdrawal
- Electrolyte/acid-base disorder
Vitamin deficiencies
- Vitamin A deficiency
- Vitamin B deficiencies
- Vitamin B1 deficiency (Thiamine)
- Vitamin B3 deficiency (Pellagra)
- Vitamin B9 deficiency (Folate)
- Vitamin B7 deficiency (Biotin)
- Vitamin B12 deficiency
- Vitamin C deficiency (Scurvy)
- Vitamin D deficiency (Rickets)
- Vitamin E deficiency
- Vitamin K deficiency
- Zinc deficiency
- Other diagnoses to consider:
- Stroke/cerebellar infarction (can mimic entire triad — ophthalmoplegia, ataxia, AMS)
- Hepatic encephalopathy
- Hypoglycemia
- Sepsis-associated encephalopathy
- Meningitis/encephalitis
- Metronidazole-induced encephalopathy (similar MRI findings; can coexist in malnourished patients on metronidazole)
- Creutzfeldt-Jakob disease (CJD — may have similar thalamic/basal ganglia signal changes on MRI, but spares mammillary bodies)
- Carbon monoxide poisoning
- Central pontine myelinolysis
- Delirium tremens
Evaluation
Workup
- WE is a clinical diagnosis — do NOT delay treatment for workup
- Labs (to exclude alternative diagnoses and identify co-morbid conditions):
- BMP— electrolytes, glucose, renal function, hepatic function
- CBC
- Magnesium level — critical; hypomagnesemia causes resistance to thiamine therapy
- Lactate — may be elevated (thiamine is a cofactor for pyruvate dehydrogenase)
- Blood alcohol level
- Serum thiamine level (whole blood thiamine preferred over serum/plasma):
- Draw before administering thiamine if possible, but never delay treatment to obtain
- Normal range generally 70-180 nmol/L, but sensitivity and specificity are poorly defined
- A normal thiamine level does NOT exclude WE[3]
- Other labs as clinically indicated: TSH, ammonia, lipase, toxicology screen, blood cultures
- Consider lumbar puncture if meningitis/encephalitis suspected — CSF in WKS typically shows normal or mildly elevated protein without pleocytosis
Imaging
- CT head: sensitivity only ~13% for WE; primary role is to exclude other pathology (hemorrhage, mass, infarct)[4]
- MRI brain (best imaging modality if obtained):
- Sensitivity ~53%, specificity ~93%, positive predictive value ~89%
- MRI is better at confirming the diagnosis than ruling it out
- A normal MRI does NOT exclude WE — do not withhold treatment based on normal imaging
- Classic findings: bilateral, symmetric T2/FLAIR hyperintensities in:
- Mammillary bodies (most distinctive finding; contrast enhancement may be pathognomonic)
- Periventricular/medial thalamus
- Periaqueductal gray matter
- Tectal plate
- Cerebellar vermis (atypical but recognized)
- DWI may show restricted diffusion (helps differentiate vasogenic vs cytotoxic edema)
- Findings may normalize within days of starting thiamine therapy
- Sensitivity ~53%, specificity ~93%, positive predictive value ~89%
- Communicate suspected diagnosis to radiologists so protocols optimized for mammillary bodies, thalami, and periaqueductal region are used
Diagnosis
- Clinical diagnosis — maintain high index of suspicion
- Caine criteria (operational diagnostic criteria; ~85% sensitive when ≥2 present)[5]:
- Nutritional deficiency (any state, not just alcoholism)
- Ocular findings (ophthalmoplegia, nystagmus)
- Cerebellar dysfunction (ataxia)
- Altered mental status or mild memory impairment
- Per EFNS guidelines, clinical diagnosis of WE in alcoholics requires at least 2 of the following[6]:
- Dietary deficiencies
- Ocular findings (ophthalmoplegia, nystagmus)
- Cerebellar dysfunction (ataxia)
- Mental status change or mild memory impairment
Management
If you suspect, then treat! Confirming diagnosis is difficult, treatment is low risk and effective, and morbidity/mortality is high if untreated
Acute Treatment
- Thiamine — IV administration is critical; oral absorption is unreliable in at-risk patients
- Royal College of Physicians / UK guideline (widely adopted):
- 500 mg IV over 30 min TID x 2-3 days → then 250 mg IV/IM once daily x 3-5 days → then 100 mg PO daily until patient no longer at risk
- EFNS guideline:
- 200 mg IV TID (diluted in 100 mL NS or D5W, infused over 30 min)
- 100 mg/day (e.g., banana bag dose) is likely insufficient — especially in patients with alcohol use disorder
- Thiamine has a short half-life (~96 min); multiple daily doses are more effective than once-daily dosing
- Overall safety of thiamine is very good; anaphylaxis risk with IV thiamine is rare
- Royal College of Physicians / UK guideline (widely adopted):
Key Principles
- Give thiamine BEFORE glucose in any at-risk patient requiring dextrose
- Glucose without thiamine can precipitate or worsen WE by driving remaining thiamine intracellularly
- If both are urgently needed (e.g., symptomatic hypoglycemia), give them simultaneously — do not withhold glucose to wait for thiamine
- Give magnesium
- Magnesium is a cofactor for thiamine-dependent enzymes
- Hypomagnesemia may cause resistance to thiamine therapy
- Replete magnesium early and aggressively
- Replete other vitamins/electrolytes as indicated (folate, multivitamin, pyridoxine)
- Monitor for refeeding syndrome in severely malnourished patients
- Treatment response can take days to weeks; lack of immediate improvement does not exclude WE
Treatment Response (Expected Timeline)
- Oculomotor dysfunction: often begins improving within hours to days
- Confusion/encephalopathy: may take days to weeks
- Ataxia: slowest to improve; may be permanent
- Korsakoff psychosis: largely irreversible once established
Common Pitfalls
| Pitfall | Correct Approach |
|---|---|
| Believing WE only affects alcoholics | Any nutritionally deficient state can cause WE — consider post-bariatric surgery, cancer, hyperemesis, critical illness |
| Waiting for the complete classic triad | Triad present in only ~10%; any component + risk factor should prompt treatment |
| Using 100 mg IV thiamine (banana bag) as treatment dose | 100 mg is prophylactic, not therapeutic; treatment requires 200-500 mg IV TID |
| Relying on labs/imaging to confirm before treating | Clinical diagnosis; normal thiamine levels and normal MRI do NOT exclude WE |
| Withholding glucose to wait for thiamine | If hypoglycemia is symptomatic, give both simultaneously; do not delay glucose |
| Forgetting to check/replete magnesium | Hypomagnesemia impairs thiamine utilization; always co-replete |
| Confusing WE with cerebellar stroke | Both present with ophthalmoplegia, ataxia, AMS — always consider WE in differential |
Medication Dosing
Thiamine 500mg IV over 30min TID x 2-3 days, then 250mg IV/IM daily x 3-5 days, then 100mg PO daily IV — 100mg (banana bag dose) is prophylactic only, NOT therapeutic; treatment requires 200-500mg IV TID
Disposition
- Admit (inpatient medicine or neurology service)
- Ensures continued IV thiamine and magnesium administration
- Observation for development of Korsakoff syndrome
- Evaluation for cardiovascular beriberi
- Address underlying cause of thiamine deficiency
- <25% of patients show full recovery, ~50% show partial recovery, the remainder show no response despite treatment[7]
- ~80% of patients with untreated WE develop Korsakoff syndrome
- Refer patients with alcohol use disorder to cessation programs; monitor for alcohol withdrawal
Prevention
- Give parenteral thiamine to all at-risk patients presenting to the ED — do not wait for symptoms
- After bariatric surgery: follow thiamine status for at least 6 months; supplement parenterally as needed
Vitamin Prophylaxis for Chronic alcoholics
- At risk for thiamine deficiency, but no symptoms: thiamine 100mg PO q day
- Give multivitamin PO; patient at risk for other vitamin deficiencies
Banana bag
The majority of chronic alcoholics do NOT require a banana bag[8][9]
- Thiamine 100mg IV
- Folate 1mg IV (cheaper PO)
- Multivitamin 1 tab IV (cheaper PO)
- Magnesium sulfate 2mg IV
- Normal saline as needed for hydration
See Also
- Ethanol toxicity
- Alcohol use disorder
- Alcohol withdrawal
- Electrolyte/acid-base disorder
External Links
- Emergency Care BC: Wernicke's Encephalopathy Diagnosis and Treatment
- EMCrit IBCC: Thiamine Deficiency and Wernicke Encephalopathy
- StatPearls: Wernicke Encephalopathy
References
- ↑ Donnino MW, Vega J, Miller J, Walsh M. Myths and misconceptions of Wernicke's encephalopathy: what every emergency physician should know. Ann Emerg Med. 2007;50(6):715-21.
- ↑ Sinha S, Kataria A, Kolla BP, et al. Wernicke Encephalopathy-Clinical Pearls. Mayo Clin Proc. 2019;94(6):1065-1072.
- ↑ Ono K, Hayano S, Kashima M. Wernicke encephalopathy: limitations in a laboratory and radiological diagnosis. BMJ Case Rep. 2023;16(12):e254786.
- ↑ Medscape. Wernicke Encephalopathy Workup. Available at: https://emedicine.medscape.com/article/794583-workup
- ↑ Caine D, Halliday GM, Kril JJ, Harper CG. Operational criteria for the classification of chronic alcoholics: identification of Wernicke's encephalopathy. J Neurol Neurosurg Psychiatry. 1997;62(1):51-60.
- ↑ Galvin R, Bråthen G, Ivashynka A, et al. EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy. Eur J Neurol. 2010;17(12):1408-18.
- ↑ https://www.alz.org/alzheimers-dementia/what-is-dementia/types-of-dementia/korsakoff-syndrome
- ↑ Krishel, S, et al. Intravenous Vitamins for Alcoholics in the Emergency Department: A Review. The Journal of Emergency Medicine. 1998; 16(3):419–424.
- ↑ Li, SF, et al. Vitamin deficiencies in acutely intoxicated patients in the ED. The American Journal of Emergency Medicine. 2008; 26(7):792–795.
